-+ 0.00%
-+ 0.00%
-+ 0.00%

Catheter Precision Receives FDA Clearance For Its VIVO System To Expand Labeling In Its Indications For Use Statement

Benzinga·11/02/2026 13:12:05

Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced that its VIVO system has received FDA 510(k) clearance for expanded labeling in its Indications for Use statement.

The VIVO system is now cleared for a broader patient population, specifically individuals with structural heart disease (SHD) who are undergoing catheter ablation for monomorphic ventricular tachycardia (VT).